Luke Miels on GSK internal changes, ‘very busy’ BD scene

GSK has been reworking its R&D process, complete with a recent revamp on the research side. And according to chief commercial officer Luke Miels, the overhaul has had an impact on his team, too.

The entire organization has changed “a lot” over the past few years, Miels…
Click here to view original post

Advertisement — Advertise with Biotech Networks